Homing peptides as targeted delivery vehicles

Area of Science:

• Biomedical Engineering
• Molecular Biology
• Vascular Biology

Background:

• Organ and disease-specific molecular signatures exist on vasculature, forming a vascular
• zip code
• system.
• In vivo phage display is a method to map this vascular heterogeneity.
• Previously identified peptides specifically target various organs and pathological conditions.

Purpose of the Study:

• To profile vascular heterogeneity using in vivo phage display.
• To identify peptides that home to specific organs or disease states.
• To explore the therapeutic potential of these homing peptides for targeted delivery.

Main Methods:

• Utilizing in vivo phage display to identify organ- and disease-specific vascular tags.
• Characterizing peptides that exhibit homing capabilities to target sites.
• Investigating the role of identified receptors in tumor angiogenesis.
• Analyzing clinical trial data for peptide-targeted therapies.

Main Results:

• A vascular
• zip code
• system has been characterized.
• Numerous peptides with specific organ or disease homing properties have been identified.
• These peptides facilitate targeted delivery of various therapeutic payloads.
• Receptor identification revealed novel biomarkers, with some playing a role in tumor angiogenesis.
• Tumor-homing peptides have advanced to clinical trials with favorable safety and tolerability profiles.

Conclusions:

• The vascular
• zip code
• system offers a powerful platform for targeted delivery.
• Homing peptides represent a promising class of therapeutics with demonstrated safety in clinical trials.
• Further development of peptide-targeted therapies holds significant potential for various medical applications.